Related Experiment Video
Updated: Feb 18, 2026

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients
Published on: April 14, 2014
Neuromyelitis optica spectrum disorders in Iran
Sharareh Eskandarieh1, Saharnaz Nedjat2, Amir Reza Azimi3
1Brain and Spinal Cord Injury Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran; MS Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.
Neuromyelitis optica spectrum disorder (NMOSD) is more prevalent in females and younger individuals in Tehran. This study highlights higher rates of depression, migraine, and hypothyroidism in female NMOSD patients.
Area of Science:
- Neurology
- Epidemiology
Background:
- Neuromyelitis optica spectrum disorder (NMOSD) is a rare demyelinating disease with limited epidemiological data.
- Understanding NMOSD prevalence and characteristics is crucial for public health initiatives.
Purpose of the Study:
- To estimate the prevalence of NMOSD in the Caucasian population of Tehran, Iran.
- To investigate the serological and clinical features of NMOSD in this demographic.
Main Methods:
- A cross-sectional study conducted in Tehran from 2015-2016.
- Data collected through face-to-face interviews with 103 NMOSD patients using a structured questionnaire.
- Analysis performed using logistic regression.
Main Results:
- The prevalence of NMOSD in Tehran was 0.86 per 100,000 in 2016.
- A female to male ratio of 5:1 was observed, with a mean age at onset of 31.54 years.
- NMO-IgG positivity was found in 46.8% of patients; transverse myelitis was the primary symptom in 28.2%.
Conclusions:
- NMOSD demonstrates a significantly higher prevalence in females and younger individuals.
- Female patients showed a higher incidence of comorbid depression, migraine, and hypothyroidism.
Related Concept Videos
Photoreceptors and Visual Pathways
Glaucoma: Overview
Angle Closure Glaucoma: Treatment
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...

